Nektar Therapeutics
NKTR
#4832
Rank
$2.06 B
Marketcap
$60.98
Share price
0.10%
Change (1 day)
608.25%
Change (1 year)

Nektar Therapeutics (NKTR) - Net assets

Net assets on the balance sheet as of March 2026 : $0.57 Billion USD

According to Nektar Therapeutics 's latest financial reports the company has $0.57 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Nektar Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$89.83 M47.9%
2024-12-31$$60.73 M-53.63%
2023-12-31$$0.13 B-64.27%
2022-12-31$$0.36 B-46.04%
2021-12-31$$0.67 B-36.92%
2020-12-31$$1.07 B-23.35%
2019-12-31$$1.40 B-18.18%
2018-12-31$$1.71 B1855.61%
2017-12-31$$87.82 M-0.34%
2016-12-31$$88.12 M1270.74%
2015-12-31$$6.42 M-82.3%
2014-12-31$$36.33 M-140.41%
2013-12-31$-$89.91 Million-291.21%
2012-12-31$$47.01 M-76.23%
2011-12-31$$0.19 B118.19%
2010-12-31$$90.66 M-11.43%
2009-12-31$$0.10 B-46.17%
2008-12-31$$0.19 B-11.32%
2007-12-31$$0.21 B-5.56%
2006-12-31$$0.22 B-30.52%
2005-12-31$$0.32 B-30.07%
2004-12-31$$0.46 B184.63%
2003-12-31$$0.16 B-20.59%
2002-12-31$$0.20 B-23.51%
2001-12-31$$0.27 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
$81.18 B 13,989.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$90.40 B 15,589.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.19 B 1,494.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$6.01 B 944.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$45.93 B 7,871.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$47.38 B 8,123.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
$0.15 B-72.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
$1.75 B 203.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland